BerGenBio regularly presents clinical and pre-clinical data at leading scientific congresses and shares company updates at investor relation conferences. Below are presentations given by the company’s senior management and clinical collaborators.
5th Annual Nordic-American Life Science Conference
Presentation and Panel Discussion from the NALS Conference
3 December 2020
Solebury Trout Podcast Interview, 30th November 2020
Podcast Interview: CEO of BerGenBio Richard Godfrey interviewed by Scientific Advisor Neil Canavan from Solebury Trout.
Solebury Trout Zoomside Chat, 1st September
Live 1-2-1 interview with USA analyst Soumit Roy from Jones Trading.
BerGenBio ASCO 2018 investor call: June 4 2018 at 15:30 CET
- Standard International Dial-In: +44 (0) 2071 928000
- United States Dial-In: 16315107495
- Participant Code: 4352428